Recursion Pharmaceuticals (RXRX.US) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

Dec19

Recursion Pharmaceuticals CEO Plans to Sell 40,000 Shares

14:57

Dec17

JPMorgan upgrades Recursion Pharmaceuticals rating

14:02

Dec9

Recursion Pharmaceuticals Shares Show Initial Rebound, Undervalued and Advised for Exploration of Investment Opportunities

06:08

Dec8

Recursion Pharma's Drug REC-4881 Shows Promising Results in Clinical Trials

12:30

Dec6

Recursion Pharmaceuticals CEO Announces Sale of Common Stock

00:20

Dec4

Blake Borgeson reports disposal of Recursion Pharmaceuticals common stock

21:52

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 5.175 M, Net Income -162.25 M, EPS -0.3629

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 19.22 M, Net Income -171.9 M, EPS -0.4118

May5

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 14.75 M, Net Income -202.49 M, EPS -0.5027

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change